OvaScience to Present at the Boston CEO Conference
CAMBRIDGE, Mass., Jun 07, 2012 -- OvaScience™, a fertility company focused on the discovery, development and commercialization of new treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Boston CEO 2012 Conference on Monday, June 11 and Tuesday, June 12, 2012 at the Mandarin Oriental in Boston.
OvaScience is a fertility company focused on the discovery, development and commercialization of new treatments for infertility. OvaScience is working to improve the treatment of female infertility based on patented technology exclusively licensed from Massachusetts General Hospital. The company's team of scientists, physicians and advisers includes recognized leaders in the field of reproductive medicine.